NCT01870700View on ClinicalTrials.gov

Lactobacillus Reuteri in Adult With Functional Chronic Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Functional Constipation
Interventions
DRUG

lactobacillus reuteri

Lactobacillus reuteri (DSM 17938) was administered in the dose of 108 colony-forming units (CFU) in tablets of a commercially available preparation (Reuflor, Italchimici, Pomezia; BioGaia AB, Stockholm, Sweden), 30 minutes after feeding, twice per day for 4 weeks

DRUG

placebo

a supplementation with placebo was administered in tablets of a commercially available preparation 30 minutes after feeding, twice per day for 4 weeks

Trial Locations (1)

00168

Catholic University Sacred Heart, Rome

All Listed Sponsors
lead

Catholic University, Italy

OTHER

NCT01870700 - Lactobacillus Reuteri in Adult With Functional Chronic Constipation | Biotech Hunter | Biotech Hunter